Wockhardt Share Price
2011.60+61.00 (+3.13%)
+35.19% past 1 Year
Wockhardt is a pharmaceutical and biotechnology company. The Company's businesses include manufacture and marketing of pharmaceutical and bio-pharmaceutical formulations, active pharmaceutical ingredients (APIs) and vaccines.
Corporate filings & documents
Announcements
Pursuant to Regulation 30 (read with Part A of Schedule III) of SEBI (LODR) Regulations 2015 we wish to inform you that the Company is in receipt of an Adjudication Order passed by Commissioner of Customs Nhava Sheva-II JNCH.
1 week agoPursuant to Regulation 30 (read with Part A of Schedule III) of SEBI (LODR) Regulations 2015 we wish to inform you that the Company is in receipt of an Adjudication Order passed by Commissioner of Customs Nhava Sheva-II JNCH.
1 week agoPursuant to Regulation 30 read with Schedule III Part A Para A of the SEBI (LODR) Regulations 2015 we enclose herewith a copy of newspaper advertisement published today i.e. 25th August 2026 regarding the opening of special window for re-lodgment of transfer requests of shares held in physical form
1 week agoPursuant to Regulation 30 read with Schedule III Part A Para A of the SEBI (LODR) Regulations 2015 we enclose herewith a copy of newspaper advertisement published today i.e. 25th August 2026 regarding the opening of special window for re-lodgment of transfer requests of shares held in physical form
1 week agoPlease find enclosed herewith Scrutinizers Report on the combined voting results of remote e-voting and e-voting during the 27th AGM of the Company
3 weeks agoPlease find enclosed herewith Scrutinizers Report on the combined voting results of remote e-voting and e-voting during the 27th AGM of the Company
3 weeks agoPursuant to Regulation 30 read with Para A of Part A of Schedule III of SEBI (LODR) Regulations 2015 the Proceedings of the 27th AGM of the Company
3 weeks agoPursuant to Regulation 30 read with Para A of Part A of Schedule III of SEBI (LODR) Regulations 2015 the Proceedings of the 27th AGM of the Company
3 weeks agoPursuant to Regulation 32(6) of SEBI (LODR) Regulations 2015 read with Regulation 173A of SEBI (ICDR) Regulations 2018 please find enclosed Monitoring Agency Report towards utilisation of proceeds of Qualified Institutions Placement (QIP) for the quarter ended 30th June 2026 issued by CRISIL Ratings Limited duly reviewed and taken on record by the Board of Directors and Audit Committee of the Company.
3 weeks agoPursuant to Regulation 32(6) of SEBI (LODR) Regulations 2015 read with Regulation 173A of SEBI (ICDR) Regulations 2018 please find enclosed Monitoring Agency Report towards utilisation of proceeds of Qualified Institutions Placement (QIP) for the quarter ended 30th June 2026 issued by CRISIL Ratings Limited duly reviewed and taken on record by the Board of Directors and Audit Committee of the Company.
3 weeks agoPlease find enclosed Press Release - "Wockhardt Antibiotic Academy an initiative for Patient-Centric Scientific Dialogue to Tackle Multidrug Resistance".
3 weeks agoPlease find enclosed Press Release - "Wockhardt Antibiotic Academy an initiative for Patient-Centric Scientific Dialogue to Tackle Multidrug Resistance".
3 weeks agoPursuant to Regulation 30 of Listing Regulations please find enclosed Press Release on the Unaudited Financial Results (Standalone and Consolidated) for the quarter ended 30th June 2026
3 weeks agoPursuant to Regulation 30 of Listing Regulations please find enclosed Press Release on the Unaudited Financial Results (Standalone and Consolidated) for the quarter ended 30th June 2026
3 weeks agoPursuant to Regulation 30 of SEBI Listing Regulations the Board of Directors at its meeting held today i.e. 10th August 2026 has approved the Unaudited Financial Results (Standalone & Consolidated) for the quarter ended 30th June 2026.
3 weeks agoPursuant to Regulation 30 of SEBI Listing Regulations the Board of Directors at its meeting held today i.e. 10th August 2026 has approved the Unaudited Financial Results (Standalone & Consolidated) for the quarter ended 30th June 2026.
3 weeks agoPursuant to Regulation 30 of SEBI Listing Regulations Board of Directors at its meeting held today i.e 10th August 2026 has approved the Unaudited Financial Results (Standalone and Consolidated) for the quarter ended June 30 2026
3 weeks agoPursuant to Regulation 30 of SEBI Listing Regulations Board of Directors at its meeting held today i.e 10th August 2026 has approved the Unaudited Financial Results (Standalone and Consolidated) for the quarter ended June 30 2026
3 weeks agoPursuant to Regulation 30 read with schedule III (Part A Para A) and other applicable regulations of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 please find enclosed the copies of Newspaper extracts regarding the addendum to the Notice of 27th Annual General Meeting of the Company.
3 weeks agoPursuant to Regulation 30 read with schedule III (Part A Para A) and other applicable regulations of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 please find enclosed the copies of Newspaper extracts regarding the addendum to the Notice of 27th Annual General Meeting of the Company.
3 weeks agoPlease find enclosed herewith the addendum to the Notice of the 27th Annual General Meeting of the Company scheduled to be held on Monday 10th August 2026.
4 weeks agoPlease find enclosed herewith the addendum to the Notice of the 27th Annual General Meeting of the Company scheduled to be held on Monday 10th August 2026.
4 weeks agoWockhardt Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/08/2026 inter alia to consider and approve Pursuant to Regulation 29(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we wish to inform you that a meeting of the Board of Directors of the Company will be held on Monday 10th August 2026 inter-alia to consider and approve the Un-audited Financial Results (Standalone & Consolidated) of the Company for the quarter ended 30th June 2026.In view of the above the trading window for dealing in the shares of the Company which was closed from Wednesday 1st July 2026 shall remain closed until 48 hours after the declaration of Financial Results on 10th August 2026.
1 month agoWockhardt Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/08/2026 inter alia to consider and approve Pursuant to Regulation 29(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we wish to inform you that a meeting of the Board of Directors of the Company will be held on Monday 10th August 2026 inter-alia to consider and approve the Un-audited Financial Results (Standalone & Consolidated) of the Company for the quarter ended 30th June 2026.In view of the above the trading window for dealing in the shares of the Company which was closed from Wednesday 1st July 2026 shall remain closed until 48 hours after the declaration of Financial Results on 10th August 2026.
1 month agoPlease find enclosed the copies of Newspaper Advertisement published today i.e. 18th July 2026 in respect to the information regarding the 27th Annual General Meeting (AGM) of the Company Completion of dispatch of Notice of AGM and Annual Report for FY 2026 and Information about remote e-voting and e-voting facility at AGM.
1 month agoPlease find enclosed the copies of Newspaper Advertisement published today i.e. 18th July 2026 in respect to the information regarding the 27th Annual General Meeting (AGM) of the Company Completion of dispatch of Notice of AGM and Annual Report for FY 2026 and Information about remote e-voting and e-voting facility at AGM.
1 month agoPlease find enclosed the Business Responsibility and Sustainability Report and Independent Assurance Statement on BRSR Core parameters issued by SGS India Private Limited for the Financial Year ended 31st March 2026.
1 month agoPlease find enclosed the Business Responsibility and Sustainability Report and Independent Assurance Statement on BRSR Core parameters issued by SGS India Private Limited for the Financial Year ended 31st March 2026.
1 month agoPlease find enclosed herewith the Annual Report of the Company for the Financial Year 2025-26.
1 month agoPlease find enclosed herewith the Annual Report of the Company for the Financial Year 2025-26.
1 month agoPlease find enclosed herewith the Notice of 27th Annual General Meeting of Wockhardt Limited scheduled to be held on Monday 10th August 2026 at 3:30 p.m. through Video Conferencing/ Other Audio Visual Means and the Annual Report of the Company for the Financial Year 2025-2026.
1 month agoPlease find enclosed herewith the Notice of 27th Annual General Meeting of Wockhardt Limited scheduled to be held on Monday 10th August 2026 at 3:30 p.m. through Video Conferencing/ Other Audio Visual Means and the Annual Report of the Company for the Financial Year 2025-2026.
1 month agoPursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018 please find enclosed the Certificate received from MUFG Intime India Private Limited Registrar and Share Transfer Agent of the Company for the quarter ended 30th June 2026.
1 month agoPursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018 please find enclosed the Certificate received from MUFG Intime India Private Limited Registrar and Share Transfer Agent of the Company for the quarter ended 30th June 2026.
1 month agoPursuant to Regulation 30 read with Schedule III (Part A Para A) of SEBI Listing Regulations please find enclosed herewith newspaper extracts of public notice relating to 27th AGM of the Company published in Lokmat (marathi) - Chhatrapati Sambhajinagar edition and Business Standard (english) - All India editions on Friday 3rd July 2026
2 months agoPursuant to Regulation 30 read with Schedule III (Part A Para A) of SEBI Listing Regulations please find enclosed herewith newspaper extracts of public notice relating to 27th AGM of the Company published in Lokmat (marathi) - Chhatrapati Sambhajinagar edition and Business Standard (english) - All India editions on Friday 3rd July 2026
2 months agoPursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 Please find enclosed herewith newspaper advertisement published today i.e. 26th June 2026 regarding the opening of special window for re-lodgment of the transfer of shares held in physical form.
2 months agoPursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 Please find enclosed herewith newspaper advertisement published today i.e. 26th June 2026 regarding the opening of special window for re-lodgment of the transfer of shares held in physical form.
2 months agoThis is to inform that pursuant to Companys Code of Conduct for regulating monitoring and reporting of trading by designated persons (the Code) the Trading Window for dealing in the equity shares of the Company will be closed from 1st July 2026 untill 48 hours after the declaration of unaudited financial results of the Company for the quarter ended 30th June 2026.
2 months agoThis is to inform that pursuant to Companys Code of Conduct for regulating monitoring and reporting of trading by designated persons (the Code) the Trading Window for dealing in the equity shares of the Company will be closed from 1st July 2026 untill 48 hours after the declaration of unaudited financial results of the Company for the quarter ended 30th June 2026.
2 months agoPursuant to Regulation 30 of the Securities and Exchange Board of India (LODR) Regulations 2015 as amended and in continuation to our letter bearing reference no. Ref.no. WOCK/SEC/SE/2025-26/015 dated 1st June 2026 please find enclosed the transcript of the Investor Meeting held on Thursday 4th June 2026 for your information and records.
2 months agoPursuant to Regulation 30 of the Securities and Exchange Board of India (LODR) Regulations 2015 as amended and in continuation to our letter bearing reference no. Ref.no. WOCK/SEC/SE/2025-26/015 dated 1st June 2026 please find enclosed the transcript of the Investor Meeting held on Thursday 4th June 2026 for your information and records.
2 months agoPursuant to Regulation 30 of SEBI (LODR) Regulations 2015 please find enclosed herewith copy of the Investor Presentation to be made at the Investor Meeting scheduled to be held on 4th June 2026.
3 months agoPursuant to Regulation 30 of SEBI (LODR) Regulations 2015 please find enclosed herewith copy of the Investor Presentation to be made at the Investor Meeting scheduled to be held on 4th June 2026.
3 months agoPursuant to Regulation 30 of the SEBI(LODR) Regulations 2015 we wish to inform you that the Company will hold an Investor Meet on Thursday 4th June 2026 at 4:00 pm IST.
3 months agoPursuant to Regulation 30 of Listing Regulations please find enclosed Press Release - "Wockhardt Receives U.S. FDA Approval for ZAYNICH (cefepime and zidebactam) a Novel Intravenous Antibiotic for the Treatment of Adult Patients with Complicated Urinary Tract Infection Including Pyelonephritis"
3 months agoPursuant to Regulation 30 of Listing Regulations please find enclosed Press Release - "Wockhardt Receives U.S. FDA Approval for ZAYNICH (cefepime and zidebactam) a Novel Intravenous Antibiotic for the Treatment of Adult Patients with Complicated Urinary Tract Infection Including Pyelonephritis"
3 months agoPursuant to Regulation 24A of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we enclose herewith the Annual Secretarial Compliance Report for the year ended 31st March 2026
3 months agoPursuant to Regulation 30 of Listing Regulations please find enclosed Press Release - "Indian drug regulator grants marketing authorization to Wockhardts breakthrough antibiotic ZAYNICH (Zidebactum/ Cefepime) for treatment of complicated urinary tract infections including pyelonephritis with concurrent Gram- negative bacteremia"
3 months agoPursuant to Regulation 30 of Listing Regulations please find enclosed Press Release - "Indian drug regulator grants marketing authorization to Wockhardts breakthrough antibiotic ZAYNICH (Zidebactum/ Cefepime) for treatment of complicated urinary tract infections including pyelonephritis with concurrent Gram- negative bacteremia"
3 months agoConcalls & investor presentations
May 2026
ConcallPresentation
Jun 2025
ConcallPresentation
May 2024
ConcallPresentation
Feb 2024
ConcallPresentation
Feb 2023
ConcallPresentation
Jan 2022
ConcallPresentation
Nov 2021
ConcallPresentation
Jul 2021
ConcallPresentation
May 2021
ConcallPresentation
Jan 2021
ConcallPresentation
Nov 2020
ConcallPresentation
Corporate Actions
Date
Type
Details
2016-11-17
Dividend
10.0
2014-11-13
Dividend
20.0
2014-02-17
Dividend
5.0
2013-11-07
Dividend
5.0
2013-08-22
Dividend
5.0
Company details
Registered office
D-4, M. I. D. C Chikalthana Chhatrapati Sambhajinagar - (Aurangabad) Maharashtra PIN: 431006 Tel No: 0240-6632222 / 6694444 Fax No: 0240-2489219 Email: [email protected] Internet: www.wockhardt.com
Registrars
C 101, 247 Park, LBS Marg, Vikhroli (W), Mumbai(Old Address:) C-13 Pannalal Silk Compound, L B S Marg, Bhandup Mumbai Maharashtra C 101, 247 Park LBS Marg Vikhroli (West) PIN: Tel No: +91 810 811 8484 Fax No: 91-022-49186060 Email: [email protected] Internet: https://in.mpms.mufg.com/
Management
Rashmi Mamtura, Company Secretary & Compliance Officer
Habil Khorakiwala, Chairman
Vinesh Kumar Jairath, Non Executive Independent Director
Akhilesh Gupta, Non Executive Independent Director
Amelia Fernandes, Non Executive Independent Director
Ahmad Javed, Non Executive Independent Director
Om Prakash Bhatt, Non Executive Independent Director
Huzaifa Khorakiwala, Executive Director
Zahabiya Khorakiwala, Non Executive Director
Murtaza Khorakiwala, Managing Director
Details
BSE 532300
NSE WOCKPHARMA
ISIN INE049B01025